Counselors in Belvidere, NJ Accepting Medicare

8 Counselors found. Showing 1 - 8

Deborah Dominicci, NAVIGATOR Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 526 Water St, Belvidere, NJ 07823 Phone: 908-475-4600

Rebekah Lynne Johnson, LCSW, LCADC Counselor - Addiction (Substance Use Disorder) Medicare: Medicare Enrolled Practice Location: 10 Hardwick St, Belvidere, NJ 07823 Phone: 774-451-5492

Kristy Lynn Romanowski, MA, LPC, LMHC, NCC Counselor - Professional Medicare: Not Enrolled in Medicare Practice Location: 516 5th St, Belvidere, NJ 07823 Phone: 908-343-4744

Ashley Marie Allen Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 115 County Road 519, Belvidere, NJ 07823 Phone: 908-246-9242

Kelli Kennedy, CMA, NAVIGATOR Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 526 Water St, Belvidere, NJ 07823 Phone: 908-475-4600

Ruth Eldred Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 526 Water St, Belvidere, NJ 07823 Phone: 908-475-4600

Megan Thorry Counselor - Professional Medicare: Not Enrolled in Medicare Practice Location: 10 Center St, Belvidere, NJ 07823 Phone: 908-319-5157

Sadi Irvine Delaney, M.S., LPC Counselor - Professional Medicare: Not Enrolled in Medicare Practice Location: 313 2nd St, Belvidere, NJ 07823 Phone: 908-320-0395    Fax: 908-320-0395

News Archive

RMC selects Allscripts EDIS to improve access to clinical information

Allscripts announced today that Northeast Alabama Regional Medical Center (RMC) has selected the Allscripts Emergency Department Information System (EDIS) to automate emergency operations and improve access to clinical information.

Scientists successfully tag serotonin transporter to track movements of single molecules

In a process akin to belling an infinitesimal cat, scientists have managed to tag a protein that regulates the neurotransmitter serotonin with tiny fluorescent beads, allowing them to track the movements of single molecules for the first time.

MedVentive announces completion of oversubscribed Series C fundraising

MedVentive announced today the completion of its oversubscribed Series C fundraising. The $10 million in capital is targeted to fuel the company's next phase of product innovation, which will expand the ability of its technology to reduce costs to purchasers while improving the quality of care to patients.

U.S. District Court rules in favor of Allergan in its patent infringement suit against Exela PharmSci

Allergan, Inc. announced today that the United States District Court for the District of Delaware ruled in favor of Allergan, Inc. in its patent infringement suit against Exela PharmSci, Inc., Exela PharmSci Pvt., Ltd. ("Exela"), Apotex, Inc. and Apotex Corp. ("Apotex") (collectively, the "Defendants") for seeking to market purported generic versions of Allergan's drugs ALPHAGAN® P (brimonidine tartrate ophthalmic solution) 0.1% and 0.15%. Specifically, after a trial in March of 2009, the Court ruled today that all five patents (U.S. Patent Nos. 6,627,210; 6,641,834; 6,673,337; 6,562,873; and 5,424,078) asserted by Allergan are valid and enforceable, that Apotex's proposed generic versions of ALPHAGAN® P 0.1% and 0.15% infringe each of the five patents, and that Exela's proposed generic version of ALPHAGAN® P 0.15% infringes U.S. Patent No. 6,641,834, which was the only patent asserted against it. Pursuant to the Hatch-Waxman Act, the United States Food and Drug Administration is required to delay approval of Defendants' proposed generic products until the last to expire of the infringed patents, which is 2022.

Reopening college campuses could initiate COVID-19 superspreading

Researchers at Stanford University in the United States have conducted a study showing that college campuses have an extremely high incidence of coronavirus disease 2019 (COVID-19) and that reopening them could initiate superspreading into neighboring communities.

Read more Medical News

› Verified 8 days ago